Patent waiver on COVID‐19 vaccine: Indonesian law perspective

The second year of the COVID-19 pandemic has not shown any sign decline. Considering that is a new virus variant, and vaccines are pharmaceutical life science products full inventions innovations, issue vaccine patents in spotlight attention world. Previously, Indonesia had taken Government's Patent Implementation mechanism for antiviral antiretroviral drugs used HIV Hepatitis B an effort to reduce price these drugs. In light global impact Pandemic causes large number victims, idea arose apply patent waiver vaccine. Second, formulate what efforts Government can take responding waiver. Results this study indicate will actually have on exclusive rights attached inventor, but implement by while respecting holders considered appropriate emergency conditions such as situation, increase supply globally provide convenience public access address waiver, fulfill health midst pandemic, still inventors.